ALAB-P.V A-Labs Capital II Corp
- Market cap
- CAD 466K
- P/E
- -
- P/B
- 3.49x
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.
Is ALAB-P.V undervalued?
Graham numberThe Graham number of A-Labs Capital II Corp cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
A-Labs Capital II Corp fundamental analysis
No fundamental analysis for A-Labs Capital II Corp yet.
A-Labs Capital II Corp stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About A-Labs Capital II Corp
A-Labs Capital II Corp. does not have significant operations. It intends to identify and evaluate assets or businesses with a view to complete a qualifying transaction in the software, hardware, and biotech sectors. The company was incorporated in 2018 and is headquartered in Vancouver, Canada.
Full company profileA-Labs Capital II Corp financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 1 quarter up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
A-Labs Capital II Corp annual financial statements (CAD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||
| Revenue | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | -56.9K | -134K | -40.0K | -140K | -171K | -27.7K | -23.2K | -50.4K | -80.1K |
| EBITDA | - | - | - | - | -171K | -27.7K | -23.2K | -50.4K | -80.1K |
| Net Income | -56.9K | -134K | -40.0K | -140K | -171K | -27.9K | -23.2K | -45.0K | -84.4K |
| EPS | -0.01 | -0.02 | -0.01 | -0.02 | -0.03 | 0.00 | 0.00 | -0.01 | -0.01 |
| Balance Sheet | |||||||||
| Total Assets | 183K | 232K | 195K | 68.0K | 27.7K | 13.4K | 269.00 | 25.1K | 26.6K |
| Total Liabilities | 16.5K | 25.1K | 28.4K | 35.5K | 166K | 180K | 190K | 260K | 182K |
| Shareholders' Equity | 166K | 207K | 167K | 32.5K | -138K | -166K | -189K | -234K | -155K |
| Cash & Short-term Investments | 165K | 232K | 195K | 68.0K | 27.7K | 13.4K | 269.00 | 25.1K | 26.6K |
| Cash Flow | |||||||||
| Operating Cash Flow | -59.6K | -65.4K | -36.7K | -133K | -40.4K | -39.3K | -13.2K | -129K | - |
| Capital Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow | - | -65.4K | -36.7K | -133K | -40.4K | -39.3K | -13.2K | -129K | - |
| Ratios | |||||||||
| ROE | -34.3% | -64.8% | -24.0% | -432.0% | - | - | - | - | - |
| ROA | -31.2% | -57.8% | -20.5% | -206.4% | -617.1% | -207.8% | -8,608.2% | -179.5% | -316.8% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
A-Labs Capital II Corp dividends
A-Labs Capital II Corp has not paid dividends in the last 8 fiscal years.
Who owns A-Labs Capital II Corp
- Insiders 41.65%
- Institutions 12.15%
- Public & others 46.21%
- Shares outstanding 5.76M
- Free float 924K
A-Labs Capital II Corp company profile
- Company name
- A-Labs Capital II Corp
- Ticker
- ALAB-P.V
- Exchange
- TSX Venture Exchange
- Sector
- Financial Services
- Industry
- Capital Markets
- Fiscal year end
- December
- Address
- 595 Howe Street, Vancouver, BC, Canada, V6C 2T5
- Website
- -
About A-Labs Capital II Corp
A-Labs Capital II Corp. does not have significant operations. It intends to identify and evaluate assets or businesses with a view to complete a qualifying transaction in the software, hardware, and biotech sectors. The company was incorporated in 2018 and is headquartered in Vancouver, Canada.
A-Labs Capital II Corp management
2- Mr. Doron Joseph CohenCEO & Director
- Mr. Noah HershcovizCFO, Sec. & Director · born 1983